Accelerate Diagnostics, Inc. announced the appointment of Hany Massarany to chairman of the company's board of directors effective February 22, 2023. Mr. Massarany replaces John Patience, who served as board chairman for 10 years. Mr. Patience will remain on the company's board of directors.

In addition to this change, the company announced the retirement of Mark Miller and Frank ten Brick from the board of directors. Accelerate is grateful to both Mr. Miller and Mr. ten Brick for their years of service and many contributions to the company. Mr. Massarany was President and Chief Executive Officer of GenMark Diagnostics, Inc., a provider of multiplex molecular diagnostic solutions, for nine years.

He has also served as President at Ventana Medical Systems and Head of Roche Tissue Diagnostics, a division of F. Hoffman-La Roche Ltd. focused on manufacturing instruments and reagents that automate tissue processing and slide staining diagnostics for cancer. Mr. Massarany has held various global leadership positions with Ventana, including Chief Operating Officer, Executive Vice President, Worldwide Operations, Senior Vice President, Corporate Strategy and Development, and Vice President, North American Commercial Operations. Mr. Massarany also held executive management positions with Bayer Diagnostics and Chiron Diagnostics, working in both the Asia Pacific region and the United States.

Mr. Massarany currently serves as a director of Biodesix, Inc., a medical diagnostics company.